Human Hypertension Artery Fibroblasts
Quick Actions
Product Overview
Description
Human Hypertension Artery Fibroblasts are central mediators of vascular remodeling and fibrosis. Their transition from quiescent structural cells to activated, pro-inflammatory myofibroblasts drives the pathological changes in arterial stiffness and lumen narrowing characteristic of sustained hypertension.
Guarantee expansion for a minimum of 2-5 population
doublings.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPH013
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization Markers
Cells test positive for the fibroblast-specific marker CD90. They are negative for von Willebrand Factor (Factor VIII), cytokeratin 18, and alpha smooth muscle actin, confirming the absence of endothelial, epithelial, and smooth muscle cells.
Quick Facts
Product Type
Human Hypertension Fibroblasts Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
